Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. (Q30807440)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q61372103)
(Q51349290)
(Q56384070)
(P304) 2525-2528
(P407) (Q1860)
(P433) 13
(P478) 21
(P577) Tuesday, July 1, 2003
(P921) (Q974135)
(Q916698)
(Q425088)
(Q233309)
(P1433) (Q400292)
(P1476) "Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971" (language: en)
(P2093) M J B Taphoorn
J Menten
R Stupp
M Frenay
J M Kros
C C D van der Rijt
Ch J Vecht
A Allgeier
T Gorlia
European Organization for Research and Treatment of Cancer Brain Tumor Group
other details
description scientific article

External Links